VBIV: VBI Vaccines Company Cash Volume

Intense competition for government contracts with pharma behemoths is driving volatility, and the cash-on-hand metric visualizes these risks, where the 0.00 level reflects current liquidity. VBI Vaccines Inc. (VBIV) is developing unique eVLP vaccines against cancer and hepatitis using innovative virus mimicry. Robotic screening stations and the automation of clinical data analysis are driving efficiency gains.
Analytical breakdowns and data insights for company vbivaccines.com (VBIV)

This indicator is formed as a combination of liquid assets and cash equivalents. This metric determines the company's ability to withstand sudden market shocks without losing operational stability. For VBI Vaccines Inc. (VBIV), the humanitarian status of its developments minimizes external risks, ensuring stable access to capital. An analysis of historical cash balances allows for an assessment of the business's real margin of safety. This chart's dynamics reveal hidden threats of inflationary depreciation of reserves.